New 13D22
New 13G81
Stated intents0
The week of 2026-03-02, 22 holders filed a new Schedule 13D and 81 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-03-06 | Blackrock Munivest Fund, Inc. | Toronto Dominion Investments LLC | 100% | SCHEDULE 13D |
| 2026-03-06 | Blackrock Munivest Fund Ii, Inc. | Toronto Dominion Investments LLC | 100% | SCHEDULE 13D |
| 2026-03-02 | Indaptus Therapeutics, Inc. | Lazar David E. | 98% | SCHEDULE 13D |
| 2026-03-06 | Coincheck Group N.V. | Monex Group, Inc. | 83.16% | SCHEDULE 13D |
| 2026-03-03 | Nomadar Corp. | Sport City Cadiz S.L. | 66.27% | SCHEDULE 13D |
| 2026-03-02 | Intelligent Group Ltd | Hong Kong Maysunshine Investment Management Co., Limited | 29.3% | SCHEDULE 13D |
| 2026-03-02 | KORE Group Holdings, Inc. | Jay Grossman | 27.65% | SCHEDULE 13D |
| 2026-03-04 | Proem Acquisition Corp I | Proem SPAC Partners I LLC | 26.1% | SCHEDULE 13D |
| 2026-03-05 | Illumination Acquisition Corp. I | Illumination Acquisition 1 Sponsor LLC | 25.7% | SCHEDULE 13D |
| 2026-03-02 | TRG Latin America Acquisitions Corp. | TRG Latin America Acquisitions LLC | 23% | SCHEDULE 13D |
| 2026-03-03 | Eagle Nuclear Energy Corp. | Blue Bird Capital Enterprises LLC | 20.88% | SCHEDULE 13D |
| 2026-03-04 | Xponential Fitness, Inc. | Voss Capital, LP | 18.2% | SCHEDULE 13D |
| 2026-03-02 | Blackrock Muniyield Quality Fund, Inc. | JPMorgan Chase & Co. | 17.26% | SCHEDULE 13D |
| 2026-03-02 | Infinity Natural Resources, Inc. | Etineles Holdings V, LLC | 16.19% | SCHEDULE 13D |
| 2026-03-03 | Jaguar Uranium Corp. | IsoEnergy Ltd. | 16.1% | SCHEDULE 13D |
| 2026-03-04 | Par Technology Corporation | Voss Capital, LP | 13.2% | SCHEDULE 13D |
| 2026-03-05 | Sabre Corp | Constellation Software Inc | 12.7% | SCHEDULE 13D |
| 2026-03-03 | Ziff Davis, Inc. | Pale Fire Capital SE | 6.9% | SCHEDULE 13D |
| 2026-03-04 | Mega Matrix Inc | Cosmic Vision Innovations Ltd | 5.66% | SCHEDULE 13D |
| 2026-03-05 | Jingbo Technology, Inc. | Hangdu Technology Ltd | 5.28% | SCHEDULE 13D |
| 2026-03-04 | Korea Fund Inc | Saba Capital Management, L.P. | 5.13% | SCHEDULE 13D |
| 2026-03-05 | Yatra Online, Inc. | Altai Capital Management, L.P. | 5.1% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-03-06 | Advisors' Inner Circle Fund III | Brown Advisory Inc | 98.72% | SCHEDULE 13G |
| 2026-03-06 | First Trust Exchange-Traded Fund VI | First Trust Portfolios L.P. | 89.16% | SCHEDULE 13G |
| 2026-03-06 | First Trust Exchange-Traded Fund VI | First Trust Portfolios L.P. | 69.64% | SCHEDULE 13G |
| 2026-03-06 | Scage Future | Chao Gao | 62.9% | SCHEDULE 13G |
| 2026-03-06 | Obook Holdings Inc. | Wang Chun Kai | 44.4% | SCHEDULE 13G |
| 2026-03-06 | Republic Power Group Ltd | Cetera Wealth Services, LLC | 37.83% | SCHEDULE 13G |
| 2026-03-02 | Intelligent Group Ltd | VL Prime Capital Limited | 29.3% | SCHEDULE 13G |
| 2026-03-04 | Innovator ETFs Trust | Brookstone Capital Management, LLC | 26.55% | SCHEDULE 13G |
| 2026-03-06 | Atlas Critical Minerals Corporation | Marc Fogassa | 24.47% | SCHEDULE 13G |
| 2026-03-05 | Star Gold Corp. | Myrmikan Gold Fund, LLC | 18.3% | SCHEDULE 13G |
| 2026-03-04 | Innovator ETFs Trust | Brookstone Capital Management, LLC | 15.13% | SCHEDULE 13G |
| 2026-03-06 | Westin Acquisition Corp | Karpus Management, Inc. | 14.94% | SCHEDULE 13G |
| 2026-03-04 | 2023 ETF Series Trust | BlackRock Portfolio Management LLC | 13.6% | SCHEDULE 13G |
| 2026-03-06 | Avalo Therapeutics Inc | Fmr LLC | 11.5% | SCHEDULE 13G |
| 2026-03-06 | Obook Holdings Inc. | Hsieh Chung Han | 11.5% | SCHEDULE 13G |
| 2026-03-04 | 2023 ETF Series Trust | BlackRock Portfolio Management LLC | 11.4% | SCHEDULE 13G |
| 2026-03-06 | Apogee Therapeutics, Inc. | T. Rowe Price Investment Management, Inc. | 11.3% | SCHEDULE 13G |
| 2026-03-06 | Nektar Therapeutics | Fmr LLC | 11.1% | SCHEDULE 13G |
| 2026-03-06 | Gpgi Inc | Fmr LLC | 10.8% | SCHEDULE 13G |
| 2026-03-05 | Quince Therapeutics, Inc. | Group One Trading LLC | 10.7% | SCHEDULE 13G |
| 2026-03-06 | Kiniksa Pharmaceuticals International, plc | Fmr LLC | 10.6% | SCHEDULE 13G |
| 2026-03-05 | RingCentral, Inc. | Vanguard Portfolio Management | 10.57% | SCHEDULE 13G |
| 2026-03-06 | TechTarget, Inc. | Lynrock Lake LP | 10.4% | SCHEDULE 13G |
| 2026-03-04 | Gauzy Ltd. | Hamilton Global Opportunities plc | 10.3% | SCHEDULE 13G |
| 2026-03-05 | Appian Corporation | Vanguard Portfolio Management | 10.06% | SCHEDULE 13G |
| 2026-03-05 | Acadia Realty Trust | Vanguard Portfolio Management | 10.01% | SCHEDULE 13G |
| 2026-03-05 | Extreme Networks Inc | Vanguard Portfolio Management | 10% | SCHEDULE 13G |
| 2026-03-06 | Agomab Therapeutics NV | Fmr LLC | 10% | SCHEDULE 13G |
| 2026-03-02 | In8bio, Inc. | Lytton Laurence W | 9.99% | SCHEDULE 13G |
| 2026-03-06 | GalaxyEdge Acquisition Corp | Feis Equities LLC | 9.98% | SCHEDULE 13G |
| 2026-03-02 | Ideal Power Inc. | Lytton Laurence W | 9.9% | SCHEDULE 13G |
| 2026-03-04 | APEX Tech Acquisition Inc. | Feis Equities LLC | 8.93% | SCHEDULE 13G |
| 2026-03-02 | Seneca Bancorp, Inc. | Amended and Restated Seneca Savings Bank, National Association Employee Stock Ownership Plan Trust | 8.9% | SCHEDULE 13G |
| 2026-03-02 | Omada Health, Inc. | Divisadero Street Capital Management, LP | 8.7% | SCHEDULE 13G |
| 2026-03-02 | Solana Co | Kathmere Capital Management, LLC | 8.7% | SCHEDULE 13G |
| 2026-03-04 | Immunic, Inc. | Deep Track Capital, LP | 8.69% | SCHEDULE 13G |
| 2026-03-04 | Apartment Investment and Management Co | Madison Avenue International LP | 8.6% | SCHEDULE 13G |
| 2026-03-06 | Draganfly Inc. | Kenneth Griffin | 8.6% | SCHEDULE 13G |
| 2026-03-06 | Ramaco Resources, Inc. | Dayah Capital LLC | 8.4% | SCHEDULE 13G |
| 2026-03-03 | Genesis Holdings Inc | Carpathia LLC | 8.3% | SCHEDULE 13G |
| 2026-03-06 | Hippo Holdings Inc | The Lennar Foundation, Inc. | 8% | SCHEDULE 13G |
| 2026-03-04 | Fortress Value Acquisition Corp. V | Alberta Investment Management Corp | 7.94% | SCHEDULE 13G |
| 2026-03-02 | Healthcare Triangle, Inc. | Orca Capital AG | 7.4% | SCHEDULE 13G |
| 2026-03-06 | TGE Value Creative Solutions Corp. | Morgan Stanley | 7.3% | SCHEDULE 13G |
| 2026-03-03 | Edesa Biotech, Inc. | Point72 Asset Management, L.P. | 7.2% | SCHEDULE 13G |
| 2026-03-06 | Rallybio Corp | Fmr LLC | 7.1% | SCHEDULE 13G |
| 2026-03-04 | APEX Tech Acquisition Inc. | Space Summit Capital LLC | 7% | SCHEDULE 13G |
| 2026-03-05 | Change Agents Corporation | Mitchell P. Kopin | 7% | SCHEDULE 13G |
| 2026-03-03 | Bicycle Therapeutics plc | Raymond Debbane | 6.3% | SCHEDULE 13G |
| 2026-03-06 | H2O America | Future Fund Board of Guardians | 6.2% | SCHEDULE 13G |
| 2026-03-05 | TRG Latin America Acquisitions Corp. | Sculptor Capital LP | 6.18% | SCHEDULE 13G |
| 2026-03-06 | Trinity Biotech plc | Novus Diagnostics Ltd. | 5.99% | SCHEDULE 13G |
| 2026-03-05 | APEX Tech Acquisition Inc. | Harraden Circle Investments, LLC | 5.96% | SCHEDULE 13G |
| 2026-03-04 | Averin Capital Acquisition Corp. | Sculptor Capital LP | 5.95% | SCHEDULE 13G |
| 2026-03-06 | Cars.com Inc. | Pale Fire Capital SICAV a.s. | 5.9% | SCHEDULE 13G |
| 2026-03-02 | Atomera Inc | CVI Investments, Inc. | 5.8% | SCHEDULE 13G |
| 2026-03-04 | Protalix Biotherapeutics Inc | MAK Capital Fund LP | 5.8% | SCHEDULE 13G |
| 2026-03-05 | Cracker Barrel Old Country Store, Inc. | Millennium Management LLC | 5.8% | SCHEDULE 13G |
| 2026-03-06 | Hut 8 Corp | Lone Pine Capital LLC | 5.6% | SCHEDULE 13G |
| 2026-03-06 | Tempus AI, Inc. | ARK Investment Management LLC | 5.44% | SCHEDULE 13G |
| 2026-03-03 | MOZAYYX Acquisition Corp. | MMCAP International Inc. SPC | 5.4% | SCHEDULE 13G |
| 2026-03-05 | Pelican Acquisition Corp | Merus Global Investments, LLC | 5.3% | SCHEDULE 13G |
| 2026-03-05 | ICL Group Ltd. | Harel Insurance Investments & Financial Services Ltd | 5.3% | SCHEDULE 13G |
| 2026-03-04 | CytomX Therapeutics, Inc. | Kynam Capital Management, LP | 5.29% | SCHEDULE 13G |
| 2026-03-04 | Cullinan Therapeutics, Inc. | Kynam Capital Management, LP | 5.27% | SCHEDULE 13G |
| 2026-03-02 | Gossamer Bio, Inc. | 683 Capital Management, LLC | 5.23% | SCHEDULE 13G |
| 2026-03-02 | Talkspace, Inc. | MAK Capital Fund LP | 5.2% | SCHEDULE 13G |
| 2026-03-02 | Paloma Acquisition Corp I | Linden Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-03-03 | Geron Corporation | Soleus Capital Master Fund, L.P. | 5.2% | SCHEDULE 13G |
| 2026-03-03 | ClearThink 1 Acquisition Corp. | Harraden Circle Investments, LLC | 5.15% | SCHEDULE 13G |
| 2026-03-02 | Protara Therapeutics, Inc. | Millennium Management LLC | 5.1% | SCHEDULE 13G |
| 2026-03-03 | Haemonetics Corp | North Peak Capital Management, LLC | 5.1% | SCHEDULE 13G |
| 2026-03-03 | Zentalis Pharmaceuticals, Inc. | Squadron Master Fund LP | 5.1% | SCHEDULE 13G |
| 2026-03-04 | Luckin Coffee Inc. | First Beijing Investment Ltd | 5.1% | SCHEDULE 13G |
| 2026-03-06 | Sunococorp LLC | Harvest Fund Advisors LLC | 5.1% | SCHEDULE 13G |
| 2026-03-05 | Star Holdings | The TCW Group, Inc., on behalf of the TCW Business Unit | 5.08% | SCHEDULE 13G |
| 2026-03-05 | OneIM Acquisition Corp. | Sculptor Capital LP | 5.05% | SCHEDULE 13G |
| 2026-03-03 | 1RT Acquisition Corp. | RP Investment Advisors LP | 5% | SCHEDULE 13G |
| 2026-03-03 | Climb Global Solutions, Inc. | AltraVue Capital, LLC | 5% | SCHEDULE 13G |
| 2026-03-05 | Gildan Activewear Inc. | Caisse de d??p??t et placement du Qu??bec | 5% | SCHEDULE 13G |
| 2026-03-05 | Ormat Technologies, Inc. | Harel Insurance Investments & Financial Services Ltd | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)104 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.